Braingaze Investors
Braingaze solves major challenges around cognitive disorders of the brain. We use a patented neuro-biomarker based on small involuntary eye movements. These are triggered by functional games, the resulting signal is analysed using algorithms trained by Deep Learning based on actual real patient / control cases. We adress pre-symptomatic stages of Alzheimer's disease and the most common child cognitive disorder ADHD. Our tools are on the market and covered by a CE Mark as a medical device. Our pipeline includes detection / diagnostic tools as well as digital therapy solutions that have shown to reduce symtoms by over 50%.
Industry:
Other
Number Of Exists:
1-10
Headquarters:
Mataró, Catalonia, Spain
Employee Number:
1-10
Technology:
Other
Founded Date:
2013
Investor Type:
Healthcare Company